| Colchicine | Takeda | ||
| 0.6mg, Tablet; Oral |
Less Than $1000 mn
|
||
|
Less Than 5
|
More Than 5
|
||
|
Less Than 5
|
None | ||
|
More Than 5
|
More Than 5
|
||
| acute gout flares and for treating familial Mediterranean fever | |||
|
Yes
| |||
| Colcrys | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ******* ******* | |||||||||||||||||
| ******* *** *********** ************** ** ********** *** ********* *********** | ******* *** *********** ************** ** ********** *** ********* *********** ** *** ********* ** **** ****** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** ********* *********** | ********** ************ *** ******* | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ********** ************ *** ******* | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** ********* *********** | ******* *** *********** ************** ** ********** *** ********* *********** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** ********* *********** | ********** ************ *** ******* | ******** ************ *** ******* | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******* ******* |
| Colchicine | Takeda | ||
| 0.3 mg; Tablet, Oral |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
|
Less Than 5
|
Less Than 5
|
||
| Colchicine (Colcrys) is a drug prescribed for the treatment of acute gout and familial Mediterranean fever (FMF). Off-label treatment uses include pseudogout, amyloidosis, and scleroderma. Side effects, drug interactions, warnings and precautions should be reviewed prior to taking any medication. | |||
|
Yes
| |||
| Colcrys | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ** ******* | |||||||||||||||||
| ******* *** *********** ************** ** ********** *** ********* *********** ** *** ********* ** **** ****** | ******* *** *********** ************** ** ********** *** ********* *********** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** ********* *********** | ********** ************ *** ******* | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ********** ************ *** ******* | ******* *** *********** ************** ** ********** *** ********* *********** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** ********* *********** | ******* *** *********** ************** ** ********** *** ********* *********** | ********** ************ *** ******* | ******** ************ *** ******* | ******* *** *********** ************** ** ********** *** * ****** ****** ***** | ******* *** *********** ************** ** ********** *** * ****** ****** ***** |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ** ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|